Vidyya Medical News Service
*
Volume 5 Issue 72 Published - 14:00 UTC 08:00 EST 13-Mar-2003 Next Update - 14:00 UTC 08:00 EST 14-Mar-2003
little clear gif used for spacer
.
*

Corporations fight over development rights to new peanut allergy drug - Patients lose patience
This week, Vidyya relayed news from New England Journal of Medicine about the promising results of clinical trials of TNX-901, a drug that helps block the allergic response to peanut allergy. Word of this major advance initially elated the 1.5 million Americans with peanut allergy, but the elation was short-lived as word spread that the clinical trials in seven research centers across the country may be halted due to a legal squabble involving Genentech, Novartis, and Tanox over development rights.  more

*
Emergency physicians decry status of uninsured in America: Uninsured delay care, live sicker, die younger
Uninsured patients are more likely to live with serious medical conditions, lack access to critical medications and forgo recommended health screenings than are people who have health insurance, according to a new survey of emergency March 12, 2003.  more

 


*
AIDS drug fails NIH trials, but marketing appears to triumph over science
British pharmaceutical giant GlaxoSmithKline Plc's AIDS drug therapy, Trizivir, the first pill to combine three HIV drugs (Ziagen, AZT and 3TC) into one twice-a-day pill, doesn't protect patients as well as some other combinations of medicines, according to scientists who suspended part of a National Institutes of Health (NIH) government study because of the findings.  more

*
Xenon shows promise in protecting brain during bypass surgery
In studies using rats, researchers from Duke University Medical Center and the Imperial College, London, have found evidence that the chemically inert gas xenon can protect the brain from the neurological damage often associated with the use of the heart-lung machine during coronary artery bypass surgery.  more

*
UCLA researcher discovers the role of common painkillers in protecting against Alzheimer's disease
In a breakthrough study, UCLA scientists have found that common painkillers such as ibuprofen and naproxen may actually dissolve the brain lesions or amyloid plaques that are one of the definitive hallmarks of Alzheimer's disease. The findings are reported in the March 31 issue of Neuroscience.  more

 
little clear gif used for a space